Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-16

Clinical Trial Update: Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating diazepam for management of refractory epilepsy in patients requiring intermittent medical intervention for acute repetitive seizures; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diazepam (Diazepam)

Snippet

Sponsor: Pfizer | Conditions: Seizures, Epilepsies, Partial | Phase 3 | Status: COMPLETED | Results posted: 2016-08-16